GL Capital, founded in 2010 by former Country President for Novartis China, Jeffrey Li, is an investment firm that focuses on buyout and growth opportunities in China’s healthcare industry. The firm has over 3.4billion USD in aggregate AUM across both public and private equity, through USD and RMB-denominated funds.

GL Capital strives to be the partner-of-choice for leading healthcare companies, generate superior returns for our investors and contribute to the sustainable development of China’s healthcare industry.